# Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

> **NCT00795132** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 47 (actual)

## Conditions studied

- Acute Leukaemia
- Chronic Disease
- Leukemia
- Myelodysplasia
- Lymphoma

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Anti-Thymocyte Globulin
- **DRUG:** Fludarabine
- **DRUG:** Cyclosporine
- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00795132
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2013-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795132, "Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00795132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*